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Introduction
PTEN (phosphatase and tensin homologue deleted on chromo-
some TEN) is the major negative regulator of signaling by phos-
phatidylinositol 3-kinase (PI 3-K), thereby playing a central role 
in controlling many important cellular activities regulated by this 
pathway, including cell division, cell growth, cell survival, and 
DNA damage (Chalhoub and Baker, 2009). PTEN exerts its 
negative effect through its phosphatase activity on the plasma 
membrane lipid phosphatidylinositol 3,4,5-triphosphate (PIP3), 
reducing levels of phosphorylated Akt (pAkt; Maehama and 
Dixon, 1998; Stambolic et al., 1998). Thus, loss of PTEN, as 
demonstrated by genetic inactivation in human cancer or mouse 
knockout (KO) models, causes constitutive activation of Akt in 
cells, resulting in dysregulated cell proliferation, growth, and sur-
vival, which are hallmarks of tumorigenesis (Hobert and Eng, 
2009; Nardella et al., 2010). PTEN can be found in both the cyto-
plasm and nucleus of many cell and tissue types, and its aberrant 
localization has been implicated in disease. The nucleocytoplas-
mic distribution of PTEN has been proposed to affect its tumor-
suppressive function both within and outside the PI 3-K pathway 
(Planchon et al., 2008). However, it has remained unclear what 
physiological stimulus can drive PTEN into the nucleus and 
under what in vivo circumstances this can occur.
In the brain, PTEN is required for multiple aspects of 
neuronal function and development, including maintenance of 
neuron structure, size, synaptic plasticity, and survival (Endersby 
PTEN (phosphatase and tensin homologue deleted on chromosome TEN) is the major negative regula-tor of phosphatidylinositol 3-kinase signaling and 
has cell-specific functions including tumor suppression. 
Nuclear localization of PTEN is vital for tumor suppression; 
however, outside of cancer, the molecular and physiologi-
cal events driving PTEN nuclear entry are unknown. In this 
paper, we demonstrate that cytoplasmic Pten was trans-
located into the nuclei of neurons after cerebral ischemia 
in mice. Critically, this transport event was dependent on a 
surge in the Nedd4 family–interacting protein 1 (Ndfip1), 
as neurons in Ndfip1-deficient mice failed to import Pten. 
Ndfip1 binds to Pten, resulting in enhanced ubiquitination 
by Nedd4 E3 ubiquitin ligases. In vitro, Ndfip1 overex-
pression increased the rate of Pten nuclear import detected 
by photobleaching experiments, whereas Ndfip1/ fibro-
blasts showed negligible transport rates. In vivo, Ndfip1 
mutant mice suffered larger infarct sizes associated with 
suppressed phosphorylated Akt activation. Our findings 
provide the first physiological example of when and why 
transient shuttling of nuclear Pten occurs and how this 
process is critical for neuron survival.
Ndfip1 regulates nuclear Pten import in vivo  
to promote neuronal survival following  
cerebral ischemia
Jason Howitt,1 Jenny Lackovic,1 Ley-Hian Low,1 Adam Naguib,4 Alison Macintyre,1 Choo-Peng Goh,1  
Jennifer K. Callaway,2 Vicki Hammond,1 Tim Thomas,3 Matthew Dixon,3 Ulrich Putz,1 John Silke,3 Perry Bartlett,5  
Baoli Yang,6 Sharad Kumar,7 Lloyd C. Trotman,4 and Seong-Seng Tan1
1Brain Development and Regeneration Laboratory, Florey Neuroscience Institutes, 2Department of Pharmacology, and 3Walter and Eliza Hall Institute of  
Medical Research, The University of Melbourne, Parkville, Victoria 3010, Australia
4Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724
5Queensland Brain Institute, University of Queensland, St. Lucia QLD 4072, Australia
6Department of Obstetrics and Gynecology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, IA 52242
7Center for Cancer Biology, SA Pathology, Adelaide SA 5000, Australia
© 2012 Howitt et al. This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub-
lication date (see http://www.rupress.org/terms). After six months it is available under a 
Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, 
as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
IO
L
O
G
Y
 o
n
 O
ctober 21, 2015
jcb.rupress.org
D
ow
nloaded from
 
Published January 2, 2012
http://jcb.rupress.org/content/suppl/2011/12/29/jcb.201105009.DC1.html 
Supplemental Material can be found at:
JCB • VOLUME 196 • NUMBER 1 • 2012 30
In the current study, we demonstrate that cerebral isch-
emia is the stimulus for trafficking of Pten to the nucleus, 
leading to neuron survival. This nuclear trafficking of Pten is 
downstream of Nedd4 family–interacting protein 1 (Ndfip1), 
an adaptor for Nedd4-mediated ubiquitination (Shearwin-
Whyatt et al., 2006). Interestingly, Ndfip1 up-regulation and 
neuronal survival were not associated with Pten degradation. 
Instead, Ndfip1 directly increases the rate of Pten transloca-
tion to cell nuclei, and, without Ndfip1 in vivo, Pten fails 
to accumulate in neuronal nuclei, resulting in larger infarct 
sizes in ischemia. Therefore, Pten ubiquitination and nuclear 
import, previously shown to be antioncogenic in the colon 
(Trotman et al., 2007; Wang et al., 2007), serve the unexpected 
function of protecting neurons from death after ischemia in 
the brain.
Results and discussion
Nuclear trafficking of Pten in neurons  
is stimulated by cerebral ischemia  
and requires Ndfip1
Under normal homeostasis, Pten is found predominantly in 
the cytoplasm of neurons in the cerebral cortex (Fig. 1, A–C). 
After ischemia, we observed a change in the cellular location 
of Pten in neurons of the periinfarct region, from the cyto-
plasm to the nucleus (Fig. 1, D–F; Pten antibody validation 
is shown in Fig. S1). This relocalization of Pten is strongly 
correlated with neurons up-regulating Ndfip1, an adaptor pro-
tein for the Nedd4 family of ubiquitin ligases (Fig. 1, A–F). 
Previously, we reported that Ndfip1 is rapidly up-regulated in 
surviving neurons after brain trauma (Sang et al., 2006); here, 
we also show that Ndfip1 is up-regulated in surviving neurons 
after brain ischemia (Fig. S2). The tight correlation of Pten 
nuclear localization with Ndfip1 up-regulation in the same 
neurons suggested that Ndfip1 could play a role in nuclear 
trafficking of Pten during ischemic stress. To determine 
whether Pten nuclear accumulation was Ndfip1 dependent, we 
conditionally deleted Ndfip1 in neurons using the Emx1-Cre 
transgene (Ndfip1loxP/loxP;Emx1-Cre+; Fig. S2; Iwasato et al., 
2000). Mutant mice were viable and exhibited normal body 
weights and brain sizes despite Emx1-specific loss of Ndfip1 
protein in neurons of the cortex (unpublished data). Similar 
to the wild-type (WT) animals, mutant neurons in a compa-
rable cortical region of the nonischemic hemisphere showed 
a predominantly cytoplasmic distribution pattern for Pten 
(Fig. 1, G–I and inset). In contrast to the WT animals, the isch-
emic hemisphere of KO animals maintained a predominantly 
cytoplasmic Pten distribution (Fig. 1, J–L and inset). Further 
confirmation of nuclear Pten accumulation was obtained in 
vitro using nuclear/cytoplasmic cell fractionation to demon-
strate that hypoxic primary neurons accumulate Pten in the 
nuclei of Ndfip1+/+ but not Ndfip1/ mice (Fig. S3). There-
fore, Pten distribution is cytoplasmic in both WT and KO cor-
tical neurons, but, in ischemic cortices, Pten nuclear accumulation 
requires the presence of Ndfip1. These in vitro and in vivo ob-
servations point to Ndfip1 as a key regulator of Pten nuclear 
import in response to this adverse physiological stimulus.
and Baker, 2008). Thus, conditional deletion of Pten in the 
brain increases astrocyte proliferation and neuron hypertrophy 
that is associated with increased dendrites and synapses 
and aberrant cerebellar development (Backman et al., 2001; 
Kwon et al., 2001, 2006). Although these phenotypes may 
be attributable to increased Akt signaling, the lack of tumor 
formation in these brains emphasizes multifaceted roles for 
Pten in neurons (Endersby and Baker, 2008; Chalhoub and 
Baker, 2009). So although Pten status might not dictate pro-
liferation in neurons, it still appears to be important for apop-
tosis during cerebral ischemia (Ning et al., 2004; Lee et al., 
2009). What is entirely unclear is the molecular mechanism 
underscoring Pten function in neuronal ischemia, despite stud-
ies advocating Pten inhibition as a possible therapeutic route 
(Chang et al., 2007; Li et al., 2009).
Figure 1. Pten nuclear import in neurons is triggered by cerebral ischemia 
and requires Ndfip1 up-regulation. (A–C) Confocal microscopy of a brain 
section in the nonischemic hemisphere of WT mice (Ndfip1loxP/loxP;Emx1-
Cre) showing low levels of basal Ndfip1 expression together with cyto-
plasmic Pten in these neurons (arrows). The inset in C shows coextensive 
staining for both proteins in the cytoplasm, whereas their nuclei (DAPI) are 
relatively devoid of both proteins. (D–F) In the ischemic cortex of WT mice 
(24 h after HI), Pten is predominantly localized in the nucleus of neurons 
(arrows) that are up-regulated for Ndfip1. The inset in F shows nuclear 
localization of Pten with double labeling for both Ndfip1 and Pten (orange) 
in the cytoplasm. (G–I) In Ndfip1 conditional KO mice (Ndfip1loxP/loxP;Emx1-
Cre+) 24 h after HI, Pten in the nonischemic cortex is localized only in the 
cytoplasm of neurons (arrows and inset). (J–L) In contrast to WT littermates 
in D–F, Pten in the ischemic cortex of Ndfip1 conditional KO mice remains 
in the cytoplasm of neurons (arrows). The inset in L shows the absence of 
Ndfip1 and nuclear exclusion of Pten after ischemia. Bar, 30 µm.
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can pull down both Pten and Nedd4-2, indicating endogenous 
interaction (Fig. 2 C).
The aforementioned results suggest that in the brain, 
Nedd4-2 may be the E3 ligase required for Pten ubiquitination. 
To further investigate this, we tested the role of Ndfip1 in 
mediating PTEN ubiquitination by either Nedd4-1 or Nedd4-2 
(Fig. 2 D). Transfected PTEN alone (Fig. 2 D, lane 1) in HEK-
293T cells showed a lack of ubiquitination. Overexpression of 
either Nedd4-1 (Fig. 2 D, lane 3) or Nedd4-2 (Fig. 2 D, lane 5) 
revealed multiple PTEN ladders corresponding to multimono-
ubiquitinated forms of PTEN (Trotman et al., 2007). These 
discrete forms of monoubiquitinated PTEN were significantly 
enhanced when Ndfip1 was cotransfected with either Nedd4-1 
(Fig. 2 D, lane 4) or Nedd4-2 (Fig. 2 D, lane 6), indicating in-
creased substrate specificity or increased ligase efficiency as a 
result of Ndfip1. In the presence of Ndfip1, the adduct forms 
that correspond to monoubiquitinated bands of PTEN (Trotman 
et al., 2007; Wang et al., 2007) appear stronger, although the 
Ndfip1 binds to and enhances 
ubiquitination of Pten
Next, we looked for a direct interaction between PTEN and 
Ndfip1. Ndfip1 acts by recruiting target proteins that lack PY 
motifs and facilitates their ubiquitination by Nedd4 E3 li-
gases (Shearwin-Whyatt et al., 2006). One member of the 
Nedd4 family, Nedd4-1, has been shown to be important for 
PTEN ubiquitination (Trotman et al., 2007; Wang et al., 
2007; Drinjakovic et al., 2010), but there is controversy 
regarding this interaction (Fouladkou et al., 2008; Wang et al., 
2008). As PTEN lacks the classical PY motifs required for 
Nedd4 binding, we investigated whether Ndfip1 may mediate 
the interaction between PTEN and the ubiquitin ligases. To 
determine whether Ndfip1 binds to PTEN, coimmunoprecip-
itation experiments were performed in human embryonic 
kidney (HEK-293T) cells (Fig. 2, A and B) and brain tissue 
(Fig. 2 C). In cells, Ndfip1 and PTEN can mutually coprecipi-
tate each other (Fig. 2, A and B), and, in brain lysates, Ndfip1 
Figure 2. Ndfip1 binds to PTEN and enhances PTEN ubiquitination by Nedd4 E3 ligases. (A) PTEN (PTEN WT) coprecipitates with Strep-Flag-NDFIP1 
(SF-NDFIP1) after expression in HEK-293T cells. IB, immunoblotted; IP, immunoprecipitated. (B) Ndfip1 coprecipitates with GFP-PTEN after expression in 
HEK-293T cells. (C) Mouse cortical lysates show coimmunoprecipitation of both Pten and Nedd4-2 with Ndfip1. (D) PTEN ubiquitin (Ub) assay using 
Ndfip1, Nedd4-1, and Nedd4-2 in HEK-293T cells. Lanes without Ndfip1 coexpression (lanes 1, 3, and 5) show decreased PTEN ubiquitination com-
pared with lanes expressing Ndfip1 (lanes 2, 4, and 6). The presence of Ndfip1 with Nedd4-1 (lane 4) or Nedd4-2 (lane 6) produced the characteristic 
monoubiquitinated ladder together with higher molecular mass–polyubiquitinated smear. (E) Phosphorylation status of PTEN changes Ndfip1 interaction. 
PTEN WT and the PTEN 3A phosphorylation-defective mutant interact strongly with Ndfip1, but PTEN 4D phosphomimic mutant interacts weakly with Ndfip1. 
(F) Ndfip1-mediated ubiquitination of PTEN is dependent on the phosphorylation status of PTEN. In the absence of Ndfip1, little PTEN ubiquitination occurs. 
Coexpression with Ndfip1 results in strong ubiquitination of the PTEN 3A phosphorylation-defective mutant, but both PTEN WT and the PTEN 4D phospho-
mimic mutant are weakly ubiquitinated.
 o
n
 O
ctober 21, 2015
jcb.rupress.org
D
ow
nloaded from
 
Published January 2, 2012
JCB • VOLUME 196 • NUMBER 1 • 2012 32
(S380A/T382A/T383A), and a phosphomimic PTEN 4D mu-
tant (S380D/T382D/T383D/S385D; Vazquez et al., 2000). We 
found that PTEN 3A was able to interact with Ndfip1 at a level 
similar to or increased compared with PTEN WT, but PTEN 4D 
interaction was weak (Fig. 2 E). In the presence of Ndfip1, 
PTEN 3A was ubiquitinated more than PTEN WT, generating 
the characteristic multimonoubiquitinated bands as well the 
polyubiquitinated smear (Fig. 2 F, fourth lane). Interestingly, 
the PTEN 4D mutant is capable of being ubiquitinated despite 
low binding to Ndfip1 (Fig. 2 F, sixth lane).
In vitro nuclear import of PTEN  
is accelerated by Ndfip1
NEDD4-1 has been shown to control PTEN monoubiquitina-
tion and nuclear import (Trotman et al., 2007). To test whether 
Ndfip1 is a mediator of this process, we measured nuclear PTEN 
transport as a function of Ndfip1 status. To this end, we used 
nuclear FRAP of cherryFP-PTEN (cherry-PTEN) in the PTEN-
deficient PC3 prostate cancer cell line, as previously described 
(Trotman et al., 2007). We first tested whether overexpression 
of GFP-Ndfip1 could affect cherry-PTEN nuclear transport. As 
shown in Fig. 3 A, recovery of nuclear PTEN fluorescence typi-
cally proceeds >800 s after nuclear bleaching. In contrast, 
cooverexpression of GFP-Ndfip1 strongly accelerated this pro-
cess such that a plateau was reached within <500 s, with an ap-
parent import rate greater than fourfold higher than what was 
observed in GFP-expressing cells (Fig. 3 E). Moreover, cells 
coexpressing both plasmids were readily able to reestablish the 
prebleach nuclear cytoplasmic signal ratios, indicating that 
upon Ndfip1 expression, a high fraction of PTEN in the cell is 
nuclear transport competent (Fig. 3 B). Next, we made use of 
the genetic system to test whether mouse Ndfip1 is an essential 
component of the PTEN import machinery and transfected 
Ndfip1+/+ and Ndfip1/ primary mouse embryonic fibroblasts 
(MEFs) with GFP-PTEN for subsequent FRAP analysis. As 
shown in Fig. 3 (C and D), Ndfip1+/+ MEFs showed PTEN im-
port curves and apparent import rates comparable with those 
observed in the PC3 cells. Yet, the Ndfip1/ cells showed 
only negligible signal recovery. As a result (Fig. 3 E), the 
KO MEFs displayed only 0.1% of the normal PTEN transport 
rate (2.4 × 106/s vs. 2.4 × 103/s for KO and WT cells, respec-
tively; Fig. 3, D and E). Collectively, our in vitro analysis shows 
that Ndfip1 is essential for PTEN import, which can be enhanced 
by Ndfip1 overexpression, in full agreement with our in vivo 
findings using Ndfip1 KO mice.
Mice lacking Ndfip1 in the brain suffer 
larger infarct sizes after cerebral ischemia
The aforementioned results indicate a causal relationship be-
tween Ndfip1 up-regulation and Pten nuclear localization in 
surviving neurons after ischemia. If Ndfip1 induction protects 
neurons from ischemic death (Sang et al., 2006), elimination 
of Ndfip1 in neurons would be expected to increase cell death 
after cerebral ischemia. To test this, we quantitated the effect 
of neuron-specific ablation of Ndfip1 (Ndfip1loxP/loxP;Nestin-
Cre+). These mutant mice were compared with littermate con-
trols (Ndfip1loxP/loxP;Nestin-Cre) 24 h after ischemia, using 
uniform smear representing polyubiquitinated PTEN (Wang 
et al., 2007; Maccario et al., 2010) is also increased. Ndfip1 
alone (Fig. 2 D, lane 2) also produced basal levels of ubiqui-
tinated PTEN, likely assisted by endogenous levels of NEDD4-2 
in HEK-293T cells (Fig. 2 D, bottom). To test this further, we 
conducted RNAi experiments to knock down either NEDD4-1 
or NEDD4-2 (Fig. S3). In the presence of Ndfip1, knockdown 
of either NEDD4-1 or NEDD4-2 decreased the overall level of 
PTEN ubiquitination, reaffirming the pivotal role of Ndfip1 in 
conjunction with both E3 ligases (Fig. S3, lanes 2, 4, and 6). 
Phosphorylation of PTEN at C-terminal residues is known to 
stabilize the enzyme by preventing its ubiquitination but re-
duces its catalytic activity; conversely, dephosphorylated PTEN is 
active but rapidly degraded (Vazquez et al., 2001; Raftopoulou 
et al., 2004). To ascertain whether or not Ndfip1-mediated 
binding and ubiquitination have a preferred form of PTEN sub-
strate, experiments were conducted between three types of 
PTEN: WT, a phosphorylation-defective PTEN 3A mutant 
Figure 3. Ndfip1 regulates PTEN nuclear import. (A) Nuclear FRAP 
analysis of cherry-PTEN shows enhanced transport upon coexpression of 
Ndfip1-GFP after photobleaching. Errors (SEM) are shown as shaded areas. 
(B) Images of typical cells from A at pre- or postbleach times and at experi-
mental end points. Relative time points are indicated. (C) Nuclear FRAP 
analysis of GFP-PTEN shows the absence of transport in Ndfip1/ MEFs 
compared with Ndfip1+/+ MEFs. Errors (SEM) are shown as shaded areas. 
(D) Images of typical cells from C at pre- or postbleach times and at ex-
perimental end points. Relative time points are indicated. (B and D) Bars, 
10 µm. (E) Quantification of FRAP analyses after expression of cherry-PTEN 
(cPTEN) alone, with GFP (+GFP) or Ndfip1-GFP (+Ndfip1), or in the indi-
cated cell type (cPTEN, n = 11; GFP, n = 4; Ndfip1, n = 5; Ndfip1+/+ and 
Ndfip1/ MEF experiments, n = 10). Values are mean ± SEM.
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neurons are increased in periinfarct areas of WT mice after 
ischemia (Fig. 4 F), indicating neuron survival (Zhao et al., 
2006), but this number is significantly reduced in mice lack-
ing Ndfip1 (Fig. 4, H and I). Thus, the loss of Ndfip1 does not 
totally abolish pAkt up-regulation in neurons after ischemia 
(Fig. 4 H) but attenuates it (Fig. 4 I), suggesting that the loss 
of Pten nuclear transport as a result of the absence of Ndfip1 
reduces pAkt levels in neurons, a result of persistent cyto-
plasmic Pten. In turn, this may lead to a greater degree of cell 
death found in Ndfip1 mutants. Additionally, loss of nuclear 
Pten may also deprive neurons of other survival benefits pro-
vided by nuclear Pten, including repairing DNA and promoting 
genome stability (Shen et al., 2007; Song et al., 2011).
In the present study, we have uncovered an altogether un-
expected facet of Pten regulation in the brain after ischemia be-
sides its known roles in normal brain development and cancer 
(Chalhoub and Baker, 2009). We show that in the normal brain, 
the role of Pten as a guardian against proliferation is recast as a 
defense against neuronal apoptosis, using almost identical pro-
tein modification pathways involving Nedd4 ubiquitination. 
Importantly, this novel Ndfip1-mediated system equips the cell 
with a dynamic and reversible Pten shuttling module that is 
geared toward improving neuron survival. It is intriguing that 
nuclear Pten import, rather than cytoplasmic Pten degradation, 
is the preferred response to this physiological stimulus, even 
2,3,5-triphenyltetrazolium chloride (TTC) staining of coronal 
slices to map the extent of infarction between the two groups 
(Fig. 4 A). Results show increased infarct areas in all brain re-
gions examined of Ndfip1loxP/loxP;Nestin-Cre+ mice compared 
with Ndfip1loxP/loxP;Nestin-Cre controls (Fig. 4 B), suggesting 
a neuroprotective role for Ndfip1.
Ndfip1-mediated ubiquitination of Pten can lead to 
either monoubiquitination promoting nuclear accumulation 
or polyubiquitination promoting Pten degradation in the cyto-
plasm. Our results show that cytoplasmic Pten levels in normal 
(nonischemic) neurons appear comparable between the two 
Ndfip1 genotypes (Fig. 1, A and G), suggesting that the ab-
sence of Ndfip1 might not compromise levels of cytoplasmic 
Pten. In ischemic neurons, some cytoplasmic Pten also remains 
present despite Pten nuclear accumulation (Fig. 1 D), suggest-
ing that the Ndfip1 surge in these neurons mediates Pten traf-
ficking rather than Pten degradation. In addition, overall Pten 
levels appear unaltered by Ndfip1 status; this was confirmed by 
Ndfip1 overexpression in SH-SY5Y neuronal cells (Fig. 4 C) 
and also in brain lysates comparing the two Ndfip1 genotypes 
(Fig. 4 D). Hence, the absence of Ndfip1 in ischemia abolishes 
nuclear transport rather than increasing cytoplasmic Pten levels 
(compare Fig. 1, A and G). To examine the effects of Pten mis-
regulation in neurons after the loss of Ndfip1 in ischemia, pAkt 
immunostaining was performed. We found that pAkt-positive 
Figure 4. Ndfip1 deletion increases neuron death after 
HI and reduces the number of pAkt-positive neurons.  
(A) Conditional KO of Ndfip1 increases total infarct size 
24 h after HI. TTC-stained brain slices show a larger infarct 
area (unstained white tissue) in Ndfip1 KO (Ndfip1loxP/
loxP;Nestin-Cre+) versus control littermates (Ndfip1loxP/
loxP;Nestin-Cre) for all ischemic regions examined (cortex, 
striatum, hippocampus, and thalamus). Bar, 2 mm. (B) The 
quantification of total infarct area indicates that Ndfip1 
KO mice sustain larger infarct size compared with control 
littermates (significant genotype effect; two-way analy-
sis of variance [ANOVA]). (C) PTEN levels in neuronal 
cell lines (SH-SY5Y) are unaffected by tamoxifen-induced 
overexpression of Ndfip1. (D) Western blot densitometry 
reveals deletion of Ndfip1 (Ndfip1loxP/loxP;Nestin-Cre+) 
does not alter Pten levels in the mouse cortex compared 
with littermate controls (Ndfip1loxP/loxP;Nestin-Cre; P = 
0.7392; two-tailed unpaired Student’s t test; n = 5 per 
genotype). (E and F) Immunostaining for pAkt in WT mice 
(Ndfip1loxP/loxP;Nestin-Cre) 24 h after HI (nonischemic 
and ischemic cortex) shows increased numbers of pAkt-
positive neurons in the periinfarct region. (G and H) In 
Ndfip1 KO mice (Ndfip1loxP/loxP;Nestin-Cre+), fewer pAkt-
positive neurons are observed in the periinfarct region 
after HI. (E–H) Insets show magnifications of the boxed 
areas. Bar, 30 µm. (I) Quantification of pAkt levels in the 
ischemic cortex 24 h after HI shows that fewer neurons 
activate Akt in the periinfarct region in Ndfip1 KO mice. 
**, P < 0.005 compared with WT (two-tailed unpaired 
Student’s t test; n = 5 per genotype). Values are mean ± 
SEM throughout.
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Unilateral cerebral hypoxia-ischemia (HI)
HI was induced in 4-wk-old male mice using a protocol adapted from 
Vannucci et al. (2001), with modifications as described. Mice were anesthe-
tized by inhalation of isoflurane (4% induction and 2% maintenance) in a 
mixture of 0.05–0.1% O2 and balanced room air. A neck incision was per-
formed, and the right common carotid artery (CCA) was exposed and dis-
sected free of surrounding tissue and nerve before permanent double ligation 
with 5–0 surgical silk. The first ligation was made immediately proximal to 
the bifurcation of the CCA into the internal and external carotid arteries with 
the second ligation made 3 mm proximal to the bifurcation. After ligation, 
the CCA was inspected to verify that blood flow had ceased and the wound 
was sutured, and the animal was allowed to recover for 3 h with free access 
to food and water. To induce HI, conscious mice were subsequently exposed 
to 40 min of systemic hypoxia in a humidified incubator containing 8% 
O2/92% N2 (model 3130; Thermo Fisher Scientific). The incubator was 
equipped with an internal O2 sensor, and O2 concentration was continu-
ously monitored throughout the hypoxic period. The incubator temperature 
was maintained between 35.5 and 35.7°C to preserve core body tempera-
ture during hypoxia (Vannucci et al., 2001). Mice were removed from the 
incubator after hypoxia and allowed to recover in a normoxic environment 
before returning to their cages with free access to food and water.
Immunohistochemistry
For Pten and pAkt immunostaining, mice were killed under deep anesthe-
sia after HI by transcardial perfusion of PBS, pH 7.4, followed by 4% PFA 
in 0.1 M phosphate buffer. Brains for Pten staining were postfixed for 1 h 
in 4% PFA in 0.1 M phosphate buffer and then cryoprotected for 24 h in 
20% sucrose in 0.1 M phosphate buffer at 4°C before coronal sectioning. 
Brains for pAkt staining were postfixed for 24 h in 4% PFA in 0.1 M phos-
phate buffer at 4°C before being paraffin embedded. For Ndfip1/TUNEL 
staining, mice were anesthetized with isoflurane and killed by decapitation 
after HI before brains were fresh frozen in Tissue-Tek (Sakura). 14 µm of 
perfusion-fixed sections was permeabilized with 0.3% Triton X-100 in 0.1 M 
phosphate buffer and blocked with 10% FBS in 0.1% Triton X-100 with 
0.1 M phosphate buffer. 8 µm of paraffin-embedded coronal sections was 
deparaffinized and microwaved in 10 mM citrate buffer, pH 6.0, to unmask 
epitopes and treated with 0.03% hydrogen peroxide for 5 min to block 
endogenous peroxidase. Tissue was then washed in PBST (0.1 M PBS and 
0.1% Triton X-100) and blocked with 10% normal horse serum in PBST. 
14 µm of fresh frozen coronal sections was fixed with 4% PFA in 0.1 M 
phosphate buffer, blocked, and permeabilized in 10% normal goat serum 
with 0.3% Triton X-100 in 0.1 M phosphate buffer. Sections were incu-
bated with primary antibodies overnight followed by appropriate second-
ary antibodies for 1 h at room temperature. Cell death was detected using 
terminal deoxynucleotidyl transferase–mediated biotinylated UTP nick-end 
labeling (TUNEL) as per the manufacturer’s instructions (Roche). Sections 
were counterstained with DAPI (1:10,000; Dako) before mounting under 
glass coverslips with antifade mounting reagent. For detection of pAkt, the 
VECTASTAIN ABC kit was used according to manufacturer’s instructions 
(Vector Laboratories). Fluorescent images of Pten/Ndfip1 staining were 
obtained at room temperature with a 40× objective (oil immersion NA 1.3) 
on a laser-scanning confocal microscope (FluoView FV1000; Olympus) 
using FV100-ASW software (Olympus). For Ndfip1/TUNEL staining, fluor-
escent images were captured at room temperature with a 10× objective 
(NA 0.03) on a fluorescent microscope (BX51; Olympus) equipped with 
a SPOT 2.3.1 camera (Diagnostic Instruments) and using Image-Pro Plus 
software (Media Cybernetics). Brightfield images of pAkt staining were 
obtained at room temperature using 10× (NA 0.30) and 40× (NA 1.00–
0.50) objectives on a fluorescent microscope (DMLB2; Leica) equipped 
with a charge-coupled device camera (Optronics ORCA-R2; Hamamatsu 
Photonics) and using Picture Frame software (MBF Bioscience). All images 
were taken at 22°C. The primary antibodies used were purified rat mono-
clonal anti-Ndfip1 (clone 1G5; 1:1,000 or 1:200 for fresh frozen sec-
tions), rabbit monoclonal anti-PTEN (clone Y184; 1:500; Abcam), mouse 
monoclonal PTEN (clone 6H2.1; 1:500; Cascade BioScience), and rabbit 
monoclonal anti-pAkt Ser 473 (1:50; Cell Signaling Technology). The sec-
ondary antibodies used were Alexa Fluor 594–conjugated goat anti–rat 
IgG (1:500; Invitrogen) and Alexa Fluor 488–conjugated goat anti–rabbit 
IgG (1:500; Invitrogen).
Evaluation of infarct area in TTC-stained sections
Mice were anesthetized by isoflurane inhalation after HI and decapitated, and 
brains were removed and sectioned in a mouse coronal brain matrix at pre-
defined 1-mm intervals. Sections were incubated in 2% TTC (Merck & Co., 
Inc.) for 30 min, rinsed in PBS, and then fixed in 4% PFA in 0.1 M phosphate 
buffer for 24 h before imaging sections on a flatbed color scanner. Infarct area 
though similar ubiquitination pathways can mediate both pro-
cesses. However, we are unable to resolve how Pten nuclear 
entry can elicit neuron survival responses at such rapid intervals, 
given that the known functions of PTEN in tumor suppression 
are quite delayed. It may be that cerebral ischemia/hypoxia 
represents a unique physiological context that accelerates 
PTEN-mediated signaling for cell survival (Ning et al., 2004). 
Nonetheless, our evidence demonstrating that Pten is not de-
graded in the cytoplasm but is imported into the nucleus for 
neuron survival presents a conceptual challenge to the existing 
dogma of promoting Pten inhibition for the treatment of stroke 
(Ning et al., 2004; Hong et al., 2006; Liu et al., 2010).
Our findings also provide the first in vivo example of an 
acute stimulus that can regulate nuclear trafficking of Pten. This 
has powerful implications for PTEN-mediated mechanisms that 
are known to operate widely in the organism under normal and 
disease settings, including development and cancer. Because 
lack of PTEN import has been demonstrated to be tumor pro-
moting (Trotman et al., 2007), it will be of interest to determine 
whether Ndfip1 alteration is implicated in neoplasia. However, it 
remains to be seen how ischemic stimuli and tumorigenic stimuli 
can both be interpreted by the cell to initiate nuclear trafficking 
of Pten and how, in postmitotic neurons, this leads to survival; 
but in dividing cancer cells, this results in tumor suppressive 
function. Given that PTEN nuclear accumulation can occur 
under a variety of conditions, including cell cycle states and hor-
monal changes (Mutter et al., 2000; Ginn-Pease and Eng, 2003), 
the downstream consequence of nuclear PTEN is likely to be 
cell and context specific. In the current instance, we demonstrate 
that in neurons, ischemic damage is a trigger for subcellular dis-
tribution of Pten with survival benefit. However, it will be of 
interest to determine whether PTEN nuclear import in all other 
scenarios is also regulated by the Ndfip1/Nedd4 system.
Materials and methods
Animals
All procedures were approved by the Florey Neuroscience Institutes Animal 
Ethics Committee. C57BL/6J mice were obtained from the Australian 
Research Council. Emx1-Cre (C57BL/6) mice were provided by T. Iwasato 
(RIKEN Brain Science Institute, Saitama, Japan; Iwasato et al., 2000), and 
Nestin-Cre mice (B6.Cg-Tg(Nes-cre)1Kln/J) were obtained from The 
Jackson Laboratory.
Generation of Ndfip1 conditional KO mice
The targeting construct was produced using homologous recombineering 
of bacterial artificial chromosome clone RP23-65L6 in Escherichia coli  
according to the method of Liu et al. (2003). Using this approach, a 10-kb 
fragment of RP23-65L6, which included exon 1 of Ndfip1, was recom-
bineered into the targeting plasmid pL253. A loxP site was inserted 962 
bp upstream of exon 1 and the Neo selection cassette flanked by FRT sites, 
and a single loxP site was inserted 1,059 bp 3 of exon 1 (Fig. S2). After 
electroporation into BRUCE 4 cells (a C57BL/6 embryonic stem cell line), 
homologously recombined embryonic stem cell clones were selected for 
production of germline chimeras. Conditional KO Ndfip1loxP/loxP;Emx1-Cre+ 
or Ndfip1loxP/loxP;Nestin-Cre+ mice were derived by crossing Ndfip1loxP/loxP 
(C57BL/6) homozygous mice with those carrying the Emx1-Cre transgene 
(Iwasato et al., 2000) or the Nestin-Cre transgene, respectively. Mice were 
genotyped by PCR of tail biopsies with the Ndfip1 floxed allele primers 
across the 5 loxP site (forward 5-TCATCCATGATGGATGTGTGC-3 and 
reverse 5-TTTACTCACAGACCCTGAGCC-3) and the Cre transgene 
primers (forward 5-TTTGCCTGCATTACCGGTCGATGCAAC-3 and 
reverse 5-TGCCCCTGTTTCACTATCCAGGTTACGGA-3).
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Western blotting
Lysates or immunoprecipitates were resolved on 10% SDS-PAGE gels fol-
lowed by transfer onto Hybond-C nitrocellulose membrane (GE Health-
care). Membranes were blocked for 1 h at room temperature in 5% nonfat 
milk in TBS and 0.05% Tween 20. Blots were incubated overnight with pri-
mary antibodies at 4°C followed by appropriate HRP-conjugated second-
aries for 1 h at room temperature. Proteins were detected using ECL reagent 
according to the manufacturer’s instructions (GE Healthcare) and visual-
ized by exposure to x-ray film. The primary antibodies used were rat mono-
clonal anti-Ndfip1 (clone 1G5; 1:2,000), rabbit monoclonal anti-PTEN 
(clone Y184; 1:2,000; Abcam), mouse monoclonal anti-PTEN (clone 
6H2.1; 1:500; Cascade BioScience), mouse monoclonal anti–StrepMAB-
Classical (1:1,000; IBA GmbH), purified rabbit polyclonal anti–Nedd4-2 
(1:1,000), mouse monoclonal anti–Nedd4-1 (clone 15; 1:1,000; BD), 
mouse monoclonal anti–-actin (clone AC-40; 1:5,000; Sigma-Aldrich), 
and mouse monoclonal anti–Flag M2 (1:1,000; Sigma-Aldrich). The HRP-
conjugated secondary antibodies used were goat polyclonal anti–rat 
(1:5,000 or 1:10,000; Millipore), goat polyclonal anti–rabbit (1:10,000; 
Millipore), and goat polyclonal anti–mouse (1:15,000; Millipore).
Photobleaching nuclear transport assays
PC3 or primary MEF cells were plated, transfected, and observed in glass-
bottom dishes (MatTek Corporation) at 24 h after transfection (MEF cells) 
or between 12 and 14 h after transfection (PC3 cells; Trotman et al., 
2007). Note that cotransfection of PC3 cells with cherry-PTEN and GFP-
Ndfip1 results in cell death after 14 h. Cotransfection was validated using 
GFP-Ndfip1 fluorescence. FRAP assays were performed on a spinning-disk 
confocal microscope (UltraVIEW VoX; PerkinElmer) using the 488- and 
561-nm laser lines (set between 3 and 13% power). All experiments were 
performed with cells growing on a heated stage at 37°C in phenol red–
free DME (Invitrogen), and imaging was performed with a 60× objective 
(NA 1.49 oil immersion). The FRAP protocol involved 12 s of imaging at 
3-s intervals of prebleach followed by bleaching and postbleach recording 
at 2-s intervals for the first 40 s and 10-s intervals for the remainder of the 
experiments, typically using between 50 and 250 ms of exposure per 
channel. Images were recorded at 512 × 672 pixels and a 12-bit depth. 
Bleaching was performed at 100% laser intensity on the entire nuclear signal, 
using between 8 and 20 cycles (total of >200 ms; step size 2). Mean nuclear 
fluorescence intensities were measured using either the FRAP Analysis or the 
region of interest functions of Volocity software (v. 5.3.2; PerkinElmer) for 
mean nuclear fluorescence calculation with background subtraction. Note that 
unspecific bleaching of fluorescence signal over the imaging period was not 
detectable. Nuclear flux rates were calculated using nonlinear curve fitting of 
Prism software (v. 5; GraphPad Software) to a pseudo-first order association 
kinetics curve using the model equation Y = Y0 + (Yindef  Y0) × (1  e(K × t)) to 
determine the apparent transport rate constant K for each series. Analyses 
were performed on at least 10 cells or on 4 cells for GFP control overexpres-
sion with cherry-PTEN and 5 cells for Ndfip1 coexpression, whereas experi-
ments were reproduced in independent biological replicates.
Statistical analysis
All data are presented as mean ± SEM unless otherwise indicated. Where 
appropriate, data were tested for normality before statistical analysis using 
the D’Agostino–Pearson test. All data were analyzed using Prism software, 
and P < 0.05 was considered statistically significant.
Online supplemental material
Fig. S1 demonstrates the specificity of the antibody Y184 for PTEN and 
compares it with the antibody 6H2.1 for immunostaining and Western 
blotting. Fig. S2 demonstrates that Ndfip1 is up-regulated in surviving neu-
rons (TUNEL negative) of WT mice after cerebral ischemia, and the genera-
tion of Ndfip1 conditional KO mice along with a Western blot confirming 
the loss of Ndfip1 protein in Ndfip1loxP/loxP;Emx-Cre+ mice is also shown. 
Fig. S3 shows the nuclear and cytoplasmic fractionation of mouse primary 
neurons after treatment with hypoxia to determine Pten localization. The 
ubiquitination of PTEN after the knockdown of endogenous Nedd4-1 and 
Nedd4-2, with and without overexpression of Ndfip1, is also demon-
strated. Online supplemental material is available at http://www.jcb.org/ 
cgi/content/full/jcb.201105009/DC1.
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was measured by planimetry of scanned sections using ImageJ software 
(National Institutes of Health), and the infarct area was calculated and cor-
rected for edema according to the method of Swanson et al. (1990).
Cell culture, transfection, and plasmid constructs
HEK-293T cells were cultured in DME (Invitrogen), 10% FCS, 4 mM 
l-glutamine, and 50 µg/ml PenStrep. Human SH-SY5Y neuroblastoma cells 
were cultured in RPMI medium (Invitrogen), 15% FCS, 2 mM l-glutamine, 
and 50 µg/ml PenStrep. HEK-293T cells were transiently transfected with 
appropriate constructs using the Effectene Transfection Reagent kit accord-
ing to the manufacturer’s instructions (QIAGEN). PC3 cells or primary MEFs 
were cultured in DME (Mediatech, Inc.), 10% FCS, 50 U/ml penicillin, 
and 100 µg/ml PenStrep and were transfected with appropriate constructs 
using Lipofectamine 2000 (for PC3; Invitrogen) or Effectene (for MEFs). 
Lentiviral infection was used to make stable SH-SY5Y cell lines of inducible 
Ndfip1-Flag. In brief, lentiviral particles were made through transfection of 
HEK-293T cells with packaging constructs plasmid cytomegalovirus ðR8.2 
and vesicular stomatitis virus glycoprotein and the Ndfip1-Flag lentiviral 
plasmid using Effectene. Supernatants were harvested, and SH-SY5Y cells 
were infected with virus supernatant for 24 h. Successful infection was se-
lected for with 2 mg/ml puromycin (Sigma-Aldrich) and 100 mg/ml hygro-
mycin B (Sigma-Aldrich) to form a stable cell line for inducible Ndfip1-Flag 
(Howitt et al., 2009). To create N terminus Strep-Flag–tagged NDFIP1, 
human NDFIP1 cDNA flanked with Nhe1 and Xho1 restriction sites was 
generated by PCR with the primers forward 5-GTGCTAGCATGGCGTT-
GGCGTTG-3 and reverse 5-GTCTCGAGATAAATAAAGAGAACTCTG-
GTCCT-3. The purified NDFIP1 PCR fragment was digested with Nhe1 
and Xho1 restriction enzymes and cloned into N-SF-TAPpcDNA3 (provided 
by C.J. Gloeckner, Institute of Human Genetics, Munich-Neuherberg, Ger-
many), generating the Strep-Flag-NDFIP1 (SF-TAP-NDFIP1pcDNA3) con-
struct. Other constructs used were GFP-PTEN in pcDNA3 (plasmid 13039; 
obtained from the Addgene plasmid repository), His-Ndfip1 in pcDNA3, 
Ndfip1-Flag in pcDNA3, PTEN WT in pcDNA3, PTEN 3A in pcDNA3, 
PTEN 4D in pcDNA3, His-Ubiquitin in pcDNA5, and Nedd4-1 and 
Nedd4-2 in pcDNA3. Cells were lysed 20 h after transfection for immuno-
precipitation assays as described in the next section. PTEN WT, PTEN 3A, 
and PTEN 4D were provided by H. Zhu (Royal Melbourne Hospital, The 
University of Melbourne, Parkville, Victoria, Australia).
Protein lysate preparation and immunoprecipitation assays
Mouse brain cortices or HEK-293T and SH-SY5Y cells were lysed in ice-
cold radioimmunoprecipitation assay buffer (50 mM Tris, pH 7.2, 0.15 
M NaCl, 2 mM EDTA, 1% NP-40, and 0.1% SDS) with protease inhibitor 
cocktail (Complete, Mini; Roche) for 20 min at 4°C. Brain homogenates 
and cell lysates were cleared of insoluble debris by centrifugation at 
13,000 rpm for 15 min at 4°C. Protein concentration of lysates was 
measured using the detergent-compatible protein assay according to the 
manufacturer’s instructions (Bio-Rad Laboratories). For precipitation ex-
periments, protein G beads (Thermo Fisher Scientific) were used for the 
precipitation of antibodies. Other beads used include Strep-Tactin (QIA-
GEN) for Strep-Flag–tagged Ndfip1 and GFP-Trap (ChromoTek) for GFP-
PTEN. For each experiment, beads were washed four times with 
radioimmunoprecipitation assay buffer before elution using the manufac-
turer’s instructions. For the ubiquitination assays, HEK-293T cells were 
transfected with His-Ubiquitin, Ndfip1-Flag or Ndfip1, PTEN WT, PTEN 
3A, PTEN 4D, Nedd4-1, and Nedd4-2. For RNAi knockdown of Nedd4 
ligases, DharmaFECT transfection reagent was used with siGENOME 
SMART pool NEDD4 (M-007178-02), NEDD4L (D-007187-04), and the 
control nontargeting siRNAi Pool #1 (D-001206-13; Thermo Fisher Scientific). 
PTEN, Ndfip1-Flag, and His-Ubiquitin were transfected 24 h after RNAi 
transfection, and ubiquitination assay was performed 48 h later. Lysates 
were immunoprecipitated with HisLink (Promega) under denaturing condition 
using 6 M guanidine HCl and N-ethylmaleimide for inhibiting the deubiq-
uitinase enzyme. Beads were washed three times before ubiquitinated 
proteins were eluted using 300 mM imidazole. Eluted fractions were sus-
pended in Laemmli buffer for SDS-PAGE and analyzed by Western blotting.
Nuclear and cytoplasmic fractionation of mouse primary neurons
Mouse primary neurons from Ndfip1loxp/loxp;Nestin-Cre and Ndfip1loxp/loxp; 
Nestin-Cre+ embryonic brains (embryonic day 16 [E16]) were cultured 
for 21 d before being exposed to hypoxia (<1% O2 and 5% CO2 at 37°C) 
for 8 h in a humidified chamber (model 3130; Thermo Fisher Scientific). 
Fractionation of primary neurons was performed using the NE-PER Nuclear 
and Cytoplasmic Extraction kit (Thermo Fisher Scientific) according to the 
manufacturer’s instructions.
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